Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration

Title
Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
Authors
Keywords
-
Journal
Publisher
Springer Nature
Online
2009-08-10
DOI
10.1007/s00417-009-1156-9

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now